|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 383.00 INR | -1.38% |
|
+1.35% | -7.00% |
| 05-18 | Aarti Drugs Limited, Q4 2026 Earnings Call, May 18, 2026 | |
| 05-15 | Aarti Drugs Limited Announces Reconstitution of Risk Committee, Effective May 15, 2026 | CI |
| Market Cap | 35.44B 373M 327M 301M 279M 530M 538M 3.61B 1.4B 17.49B 1.4B 1.37B 60.46B | P/E 2026 |
15x | P/E 2027 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 35.44B 373M 327M 301M 279M 530M 538M 3.61B 1.4B 17.49B 1.4B 1.37B 60.46B | EV / Sales 2026 |
1.14x | EV / Sales 2027 * | 1.24x |
| Free-Float |
39.84% | Yield 2026 * |
1.03% | Yield 2027 * | 1.26% |
Last Transcript: Aarti Drugs Limited
| 22-12-28 | Aarti Drugs : Loss of Share Certificates | PU |
| 22-07-10 | Aarti Drugs : Newspaper Advertisements | PU |
| 1 day | -1.38% | ||
| 1 week | +1.35% | ||
| Current month | +1.35% | ||
| 1 month | +4.76% | ||
| 3 months | +7.74% | ||
| 6 months | -5.24% | ||
| Current year | -7.00% |
| 1 week | 374.1 |  | 398.5 |
| 1 month | 365 | | 398.5 |
| Current year | 318.6 | | 415.45 |
| 1 year | 318.6 | | 574.95 |
| 3 years | 312.5 | | 645 |
| 5 years | 310.8 | | 734.35 |
| 10 years | 104.82 | | 1,025 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 79 | - | |
| Chief Executive Officer | 78 | 2007-05-31 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 43 | 2012-07-05 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 78 | 2014-03-31 | |
| Director/Board Member | 62 | 2007-05-31 | |
| Chairman | 79 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.38% | +1.35% | -22.00% | -18.64% | 373M | |
| +2.96% | +3.01% | +59.87% | +173.31% | 1,102B | |
| +3.05% | +5.23% | +72.11% | +67.81% | 643B | |
| -0.04% | +1.20% | +35.72% | +87.93% | 450B | |
| +0.59% | -2.07% | +27.62% | +22.57% | 336B | |
| -1.03% | -0.85% | +28.57% | +47.80% | 288B | |
| -2.89% | +1.11% | -27.90% | -40.76% | 222B | |
| +0.45% | +1.65% | +25.65% | +68.35% | 199B | |
| +5.21% | +7.93% | +21.99% | +83.23% | 169B | |
| +1.48% | -0.04% | -4.64% | -32.25% | 137B | |
| Average | +0.22% | +2.08% | +21.70% | +45.93% | 354.55B | |
| Weighted average by Cap. | +1.31% | +1.86% | +41.72% | +87.34% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 26.07B 275M 240M 221M 205M 390M 396M 2.66B 1.03B 12.86B 1.03B 1.01B 44.46B | 28.65B 302M 264M 243M 226M 428M 435M 2.92B 1.14B 14.14B 1.13B 1.11B 48.87B |
| Net income | 1.82B 19.2M 16.8M 15.48M 14.35M 27.24M 27.68M 186M 72.2M 899M 72.07M 70.51M 3.11B | 2.05B 21.57M 18.87M 17.39M 16.12M 30.61M 31.1M 209M 81.11M 1.01B 80.97M 79.22M 3.49B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-08 | ₹383.00 | -1.38% | 12,449 |
| 26-07-07 | ₹388.35 | +2.32% | 8,429 |
| 26-07-06 | ₹379.55 | -1.63% | 2,761 |
| 26-07-03 | ₹385.85 | +0.55% | 10,317 |
| 26-07-02 | ₹383.75 | +2.27% | 6,007 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AARTIDRUGS Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
